Fund overview & performance

Asset class

Based on three-year return


Annualized returns

Between % and %

 


Fund management

Series

Clear all filters

Canada Life Global Small-Mid Cap Equity Fund F

October 31, 2025

The fund seeks long-term capital growth by investing primarily in equities of global small- to mid-capitalization companies, either directly or through other investment funds.

Is this fund right for you?

  • Are looking for a global equity fund to hold as part of their portfolio.
  • Want a medium- to long-term investment.
  • Can handle the volatility of the stock market.

Risk Rating

Risk Rating: Medium

How is the fund invested? (as of August 31, 2025)

Asset allocation (%)

Name Percent
US Equity 59.2
International Equity 31.5
Cash and Equivalents 7.1
Canadian Equity 1.8
Other 0.4

Geographic allocation (%)

Name Percent
United States 59.2
Canada 8.9
United Kingdom 8.0
Bermuda 5.4
Japan 4.3
Jordan 2.2
Singapore 2.0
France 1.7
Switzerland 1.2
Other 7.1

Sector allocation (%)

Name Percent
Financial Services 29.8
Industrial Services 13.5
Industrial Goods 11.3
Technology 9.7
Basic Materials 9.1
Cash and Cash Equivalent 7.1
Consumer Goods 6.0
Consumer Services 5.3
Healthcare 2.9
Other 5.3

Growth of $10,000 (since inception)

Data not available based on date of inception

Fund details (as of August 31, 2025)

Top holdings %
Cash and Cash Equivalents 7.1
Academy Sports and Outdoors Inc 2.3
Assured Guaranty Ltd 2.3
Hackett Group Inc 2.3
Advance Auto Parts Inc 2.3
FTAI Aviation Ltd 2.2
MSC Industrial Direct Co Inc Cl A 2.2
International General Insurnce Hdg Ltd 2.2
Barrett Business Services Inc 2.1
Healthcare Services Group Inc 2.1
Total allocation in top holdings 27.1
Portfolio characteristics
Standard deviation 12.2%
Dividend yield 1.8%
Yield to maturity -
Duration (years) -
Coupon -
Average credit rating Not rated
Average market cap (million) $5,451.1

Understanding returns

Annual compound returns (%)

1 MO 3 MO YTD 1 YR
{{snapShot.Return1Mth|customNumber:1}}{{snapShot.Return3Mth|customNumber:1}}{{snapShot.ReturnYTD|customNumber:1}}{{snapShot.Return1Yr|customNumber:1}}
3 YR 5 YR 10 YR INCEPTION
{{snapShot.Return3Yr|customNumber:1}}{{snapShot.Return5Yr|customNumber:1}}{{snapShot.Return10Yr|customNumber:1}}{{snapShot.ReturnInception|customNumber:1}}

Calendar year returns (%)

2024 2023 2022 2021
{{snapShot.Return1YrCalendar|customNumber:1}}{{snapShot.Return2YrCalendar|customNumber:1}}{{snapShot.Return3YrCalendar|customNumber:1}}{{snapShot.Return4YrCalendar|customNumber:1}}
2020 2019 2018 2017
{{snapShot.Return5YrCalendar|customNumber:1}}{{snapShot.Return6YrCalendar|customNumber:1}}{{snapShot.Return7YrCalendar|customNumber:1}}{{snapShot.Return8YrCalendar|customNumber:1}}

Range of returns over five years (October 1, 2020 - October 31, 2025)

Best return Best period end date Worst return
Worst period end date
5.6% Sept. 2025 5.0% Oct. 2025
Average return % of periods with positive returns Number of positive periods Number of negative periods
5.3% 100.0% 2 0

Q3 2025 Fund Commentary

Market commentary

Global equities rose during the period led by emerging markets as enthusiasm for artificial intelligence investment strengthened Chinese information technology stocks. Developed market equities rose, notably in North America and Japan. U.S. stocks were supported by the macroeconomic backdrop and expectations interest-rate cuts, while Japanese equities were fueled by expectations of fiscal support.

U.S. equity markets brushed aside labour market weakness and persistent inflation to focus on strong earnings and fading recession fears. European equities declined as political volatility in France, fiscal concerns in Germany and weaker growth in peripheral economies lowered regional returns. The European Central Bank remained cautious, with markets pricing in limited monetary easing because of inflation.

Emerging market equities outperformed developed market equities, led by China. Despite weak domestic demand, a strong rebound in large-capitalization information technology stocks led markets higher.

Performance

The Fund’s overweight exposure to FTAI Aviation Ltd., Sapiens International Corp. NV and Bel Fuse Inc. contributed to performance. Overweight exposure to Kyndryl Holdings Inc., Nomad Foods Ltd. and Marex Group PLC detracted from the Fund’s performance.

At the stock level, selection within U.S. and international small-capitalization stocks detracted from performance, as did underweight exposure to international small-caps equities.

Portfolio activity

The sub-advisor added Fidelis Insurance Holdings Ltd., GlobalData PLC, Accelleron Industries AG, Cellebrite DI Ltd., Business Engineering Corp. and Bath & Body Works Inc. Atkore Inc., Sapiens and Tecan Group AG were sold. Tel Aviv Stock Exchange Ltd., Insperity Inc., Franklin Covey Co. and Pason Systems Inc. were reduced.

Outlook

U.S. tariffs increased costs for importers and squeezed the margins of exporting companies, forcing them to absorb some of the costs of sending goods abroad. Higher yields in many countries have increased the cost of debt funding, which may impact small- and medium-sized companies with higher proportional debt. Monetary policy easing from some central banks has put downward pressure on yields at the short end of the curve. The sub-advisor believes this could assist businesses with shorter debt maturations.

Royce & Associates, LP, Franklin Templeton Investments

Contact information

Toll free: 1-844-730-1633

{{ snapShot.FundName.replace("<em>", "").replace("</em>", "") }}
No matching records found.

Summary

For the period {{NAVPSPerformanceSummary.StartDate}} through {{NAVPSPerformanceSummary.EndDate}} with $10,000 CAD investment

Total returns performance

{{NAVPSPerformanceSummary.Growth | customPercentage}}

Last price

{{NAVPSPerformanceSummary.NAVPS | customCurrency}} CAD

as of market close {{NAVPSPerformanceSummary.NAVPSDate}}

Value of $10,000 investment

{{NAVPSPerformanceSummary.GrowthOfTenThousand | customCurrency}} CAD

Export to: